---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-21-062398"
form_type: "8-K"
ticker: "KTTA"
cik: "0001841330"
company_name: "Pasithea Therapeutics Corp."
filed_at: "2021-11-29T23:59:59+00:00"
generated_at: "2026-06-28T05:11:22.840642+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Pasithea Therapeutics prices $30.4M private placement of 8.68M shares and warrants at $3.50/unit.

## Summary
- Gross proceeds $30.4M from sale of 8.68M shares and accompanying warrants at $3.50 per unit.
- Warrants immediately exercisable at $3.50, expire in 5 yrs; cashless exercise and ownership limits apply.
- EF Hutton receives 9% cash fee plus 1% non-accountable expense fee and up to $70K accountable expenses.
- Proceeds to fund pre-clinical R&D, US/UK clinic businesses, and working capital; resale registration due within 15 days.

## SEC filing metadata
- accession: 0001213900-21-062398
- form_type: 8-K
- ticker: KTTA
- cik: 0001841330
- company_name: Pasithea Therapeutics Corp.
- filed_at: 2021-11-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841330/000121390021062398/0001213900-21-062398-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841330/000121390021062398/ea151423-8k_pasithea.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-21-062398
- JSON: https://secwatch.observer/filing/0001213900-21-062398.json
- Plain text: https://secwatch.observer/filing/0001213900-21-062398.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.